Self-Replicating RNA Replicon for iPS Cell Generation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating induced pluripotent stem cells (iPS) face challenges due to the integration of DNA vectors, leading to potential mutagenesis and inefficiencies in expression, particularly with daily mRNA transfections requiring multiple steps and varying expression levels.
Innovation Solution
The use of a synthetic self-replicating RNA from a modified alphavirus, such as Venezuelan Equine Encephalitis virus, to express pluripotent transcription factors, which reduces the number of transfections needed and ensures consistent high-level expression of reprogramming factors, avoiding DNA integration and simplifying the process.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If DNA vectors are used to express reprogramming factors, then expression levels can be maintained, but integration into the genome occurs causing mutagenesis
Solution Approach 1:
The patent extracts the reprogramming factor genes from DNA vector systems and places them into an RNA-based replicon system. The replicon contains only the essential replicase genes and IRES elements, while the reprogramming factors (Oct4, Sox2, Klf4, c-Myc) are expressed from separate cDNAs that do not integrate into the genome, thereby eliminating mutagenesis risk while maintaining expression.
Solution Approach 2:
The patent introduces an RNA replicon as an intermediary system between the reprogramming factors and the host cell. This replicon acts as a non-integrating carrier that can amplify and sustain expression of reprogramming factors through its self-replicating RNA mechanism, avoiding the need for DNA integration while ensuring reliable expression.
2Reliability
If multiple individual mRNA transfections are performed daily, then reprogramming factors can be expressed, but the process becomes complex and expression levels vary
Solution Approach 1:
The patent merges multiple separate transfection steps into a single transfection event. Instead of transfacting individual mRNAs for Oct4, Sox2, Klf4, and c-Myc separately each day, the invention combines all reprogramming factor cDNAs into a single plasmid or vector that is transfected once, and the RNA replicon amplifies all of them simultaneously, greatly simplifying the protocol.
Solution Approach 2:
The RNA replicon provides continuous amplification and sustains expression of reprogramming factors over multiple cell divisions without requiring repeated transfections. The self-replicating nature of the replicon ensures continuous production of reprogramming factor mRNAs, maintaining consistent expression levels throughout the reprogramming process.
3Stability of the object's composition
If DNA vectors are used for reprogramming, then stable expression can be achieved, but integrative mutation risk increases
Solution Approach 1:
The patent employs a disposable, non-integrating RNA replicon system that functions temporarily during reprogramming and then degrades naturally. The replicon RNA is not permanently retained in the cell, eliminating the risk of integrative mutation while providing sufficient expression stability during the reprogramming period. This temporary, self-limiting system achieves the desired expression stability without the long-term safety risks of DNA integration.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for the efficient generation of iPS cells with reduced integration risks and simplified protocols, achieving consistent expression of reprogramming factors over multiple cell divisions without the need for daily transfections, resulting in high yields of functional iPS clones.
Implementation Method 1
a self-replicating RNA vector, such as a modified alphavirus, to express the transcription factors
Data Source
AI summary
The disclosure provides methods and compositions useful for obtaining induced stem cells, methods of making and use thereof.